Plain-English translation of NCT05195281 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Pancreatic Cancer research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
Researchers want to understand how pancreatic cancer changes as patients receive chemotherapy treatment. By collecting tiny tissue samples from your tumor before treatment begins and again after chemotherapy, they can study the genetic and molecular makeup of your cancer at two different points. This information may help doctors better understand which cancers respond to treatment and which ones don't.
Pancreatic cancer is one of the most difficult cancers to treat, and doctors don't yet fully understand why some patients respond better to chemotherapy than others. By studying how tumors change during treatment, researchers hope to find clues that could lead to better, more personalized treatment approaches in the future.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will have two biopsy procedures (tissue sampling) as part of your regular cancer care. The first tissue sample is collected during your initial diagnostic evaluation. After you complete your chemotherapy and your doctors schedule follow-up imaging to check how your cancer has responded, you'll have a second biopsy procedure during a follow-up visit. The second sample will be used for research purposes to study how your cancer changed during treatment. Both procedures use a thin needle guided by ultrasound, which is standard practice for pancreatic cancer evaluation.
AI-generated summary from trial data ยท Jun 12, 2026 ยท Not medical advice
Italy